Bristol-Myers Squibb 2012 Annual Report Stockholder Information COMMON STOCK  FORM 10-K  ANNUAL MEETING OF STOCKHOLDERS STOCKHOLDER SERVICES  ADDITIONAL INFORMATION SHAREOWNER SERVICES PLUS PLAN SM PRODUCT NAMES AND COMPANY PROGRAMS Global products and company programs  appearing throughout in italics are referred  to herein by their registered and approved  U.S. trademarks, unless specifically noted  otherwise. Abilify  is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla  is a trademark of Bristol-Myers Squibb and Gilead Sciences, LLC. Avapro/Avalide  and  Plavix  are trademarks of Sanofi. Bydureon, Byetta  and  Symlin  are trademarks of Amylin Pharmaceuticals LLC  and AstraZeneca Pharmaceuticals LP. Delestrogen  is a trademark of JHP Pharmaceuticals, LLC. Erbitux  is a trademark of ImClone LLC. Estrace  and  Ovcon  are trademarks of Warner Chilcott Company, LLC. Gleevec  is a trademark of Novartis AG. Humira  is a trademark of AbbVie Biotechnology ltd.  Reglan  is a trademark of ANIP Acquisition Company. Truvada  is a trademark of Gilead Sciences, Inc. All other brand names are trademarks of Bristol-Myers Squibb Company or one of its subsidiaries. This Annual Report contains certain forward- looking information within the meaning of the  Private Securities Litigation Reform Act of  1995. These forward-looking statements are  based on current expectations and involve  inherent risks and uncertainties that could  cause actual outcomes and results to differ  materially from current expectations. Please  see page 27 in the Financial Review for a  discussion and description of these risks and  uncertainties. The Company undertakes no  obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise.  Information on the following subjects is available at www.bms.com:  The most recent certifications by the  Company’s chief executive officer and chief  financial officer pursuant to Section 302 of  the Sarbanes-Oxley Act of 2002 are filed as  exhibits to the Company’s Form 10-K. The  Company has also filed with the New York  Stock Exchange the most recent Annual  CEO Certification as required by Section  303A.12(a) of the New York Stock Exchange  Listed Company Manual.  The Form 10-K is also available at investor.bms.com.  Secretary  Bristol-Myers Squibb Company  345 Park Avenue  New York, NY 10154-0037  For a free copy of the Company’s Annual  Report on Form 10-K for the fiscal year  ended December 31, 2012, contact:  Ticker symbol: BMY New York Stock Exchange  Tuesday, May 7, 2013  10:00 a.m.  Bristol-Myers Squibb Company 777 Scudders Mill Road  Plainsboro, NJ 08536 All inquiries concerning stockholder accounts  and stock transfer matters – including  address changes, the elimination of duplicate  mailings and the Shareowner Services Plus Plan SM  – should be directed to the Company’s Transfer Agent and Registrar: Wells Fargo Shareowner Services 1110 Centre Pointe Curve, Suite 101  Mendota Heights, MN 55120-4100 www.shareowneronline.com 855-598-5485 (within the U.S.) 651-450-4064 (outside the U.S.) A telecommunications relay service should be used by the hearing impaired when calling the  telephone numbers above. The Shareowner Services Plus Plan is  designed for long-term investors who wish  to build share ownership in the Company’s  common stock over time. You can participate  in the plan if you are a registered holder of  the Company’s common stock. If you do  not own the Company’s common stock, you  can become a participant by making your  initial purchase through the plan. The plan  features dividend reinvestment, optional cash  purchase, share safekeeping, and share sales  and transfers. Bristol-Myers Squibb Company  has appointed Wells Fargo Shareowner Services as Administrator for the plan. The  plan is not sponsored or administered by Bristol-Myers Squibb Company. Shareowner Services Plus Plan is a Service  Mark of Wells Fargo Shareowner Services. 82 • Bristol-Myers Squibb Foundation • Clinical Trials  • Diversity and Workforce Statistics • Patient Assistance Programs • Political Contributions  • Sustainability/Environmental Programs 